Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Plos One|June 11, 2025
Saturation kinetics and specificity of transporters for L-arginine and asymmetric dimethylarginine (ADMA) at the blood-brain and blood-CSF barriersMehmet Fidanboylu, Sarah Ann ThomasPlos One|October 24, 2024
L-Arginine and asymmetric dimethylarginine (ADMA) transport across the mouse blood-brain and blood-CSF barriers: Evidence of saturable transport at both interfaces and CNS to blood effluxMehmet Fidanboylu, Sarah Ann ThomasArchivum Immunologiae Et Therapiae Experimentalis|May 29, 2010
Intercellular exchange of surface molecules and its physiological relevanceKathryn Brown, Mehmet Fidanboylu, Wilson WongPlos One|October 4, 2011
Global inhibition of reactive oxygen species (ROS) inhibits paclitaxel-induced painful peripheral neuropathyMehmet Fidanboylu, Lisa A Griffiths, Sarah J L FlattersAdvances in Pharmacology (San Diego, Calif.)|October 14, 2014
Delivery of antihuman African trypanosomiasis drugs across the blood-brain and blood-CSF barriersGayathri N Sekhar, Christopher P Watson, Mehmet Fidanboylu, et al.Brain Research|July 20, 2016
The transporter and permeability interactions of asymmetric dimethylarginine (ADMA) and L-arginine with the human blood-brain barrier in vitroChristopher P Watson, Evangelos Pazarentzos, Mehmet Fidanboylu, et al.Pharmacological Reviews|April 11, 2025
The microcirculation, the blood-brain barrier, and the neurovascular unit in health and Alzheimer disease: The aberrant pericyte is a central playerYasmin Amy Divecha, Sanketh Rampes, Sabine Tromp, et al.The Journal of Clinical Investigation|July 13, 2011
Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodentsBoyeon Lee, Douglas Clarke, Abraham Al Ahmad, et al.Plos Neglected Tropical Diseases|April 15, 2021
Drug reformulation for a neglected disease. The NANOHAT project to develop a safer more effective sleeping sickness drugLisa Sanderson, Marcelo da Silva, Gayathri N Sekhar, et al.Pageof 1